For research use only
| Cat No. | ABC-RC578H |
| Product Type | Reporter Stable Cell Line |
| Cell Type | Epithelial-like |
| Species | Mouse |
| Host Cell | B16-OVA |
| Source Organ | Skin |
| Disease | Melanoma |
| Storage | Liquid Nitrogen |
B16-OVA Luciferase Reporter Cell Line combines luciferase expression with OVA antigen for immune monitoring, tumor immunology, and drug screening.

| Species | Mouse |
| Cat.No | ABC-RC578H |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial-like |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Skin |
| Disease | Melanoma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Reporter Stable Cell Line |
| Host Cell | B16-OVA |
| Stock | In Stock |
For research use only
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
The B16-OVA Luciferase Reporter Cell Line is generated from the B16-OVA melanoma cell line, which is a mouse skin melanoma cell line that has been engineered to express both the ovalbumin (OVA) antigen and the luciferase gene. This cell line allows for the monitoring of tumor growth and immune response in vivo using bioluminescent imaging, making it particularly useful for cancer immunotherapy research.
The B16-OVA Luciferase Reporter Cell Line should be cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin. The cell line is also puromycin-resistant, and puromycin can be added to the medium at a concentration of 1µg/mL as needed for selection purposes.
This cell line is extensively used for research in tumor immunology, particularly for studying the efficacy of immunotherapeutic agents in melanoma. Its expression of luciferase facilitates the real-time tracking of tumor progression and regression in animal models.
Upon receiving the cryovial, it should be thawed rapidly in a 37°C water bath, ensuring the cap remains above the water to avoid contamination. After thawing, cells should be transferred to a centrifuge tube containing complete culture medium, centrifuged, and the supernatant discarded. Cells should then be resuspended in fresh medium, transferred to a new culture flask, and placed in a 37°C CO2 incubator for further cultivation.
Handling of the B16-OVA Luciferase Reporter Cell Line should adhere to Biosafety Level 1 (BLS-1). Personal protective equipment should be worn, and all procedures should be conducted in a biosafety cabinet to prevent contamination and ensure the safety of the handler. The cells are intended for research use only and should not be used for human or veterinary applications. Proper biocontainment and waste disposal procedures should be followed to mitigate any environmental impact.